Back

Temporary right heart catheterization in a stable state improves prognosis by optimizing guideline-directed medical therapy in patients with acute heart failure

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Acute heart failure: new insights and treatments Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Ryuichi Matsukawa

Aso Iizuka Hospital, Iizuka (Japan)

6 More presentations in this session

Presentation thumbnail
The experience of more than three hundred levosimendan administrations: what we have learned
Doctor F. Gerardo (Amadora, PT)
Abstract Slides Video
Presentation thumbnail
Albuminuria and acute heart failure. Prognostic implications and short-term mortality.
Doctor M. Galvan Ruiz (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
Two-year outcomes in acute heart failure patients stratified by left ventricular ejection fraction
Doctor A. Feuerstein (Berlin, DE)
Abstract Slides Video
Presentation thumbnail
The hemodynamic and cardiometabolic effects of butyrate infusion in ischemic cardiogenic shock
Mr L. Christensen (Aarhus N, DK)
Abstract Slides Video
Presentation thumbnail
Assessment of biomarkers for iron deficiency following acute decompensated heart failure and its outcomes: a retrospective real-world clinical cohort study
Doctor J. Johansson (Gothenburg, SE)
Abstract Slides Video

Access the full session

Session thumbnail
Acute heart failure: new insights and treatments

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Adjusting guideline-directed medical therapy during acute heart failure hospitalisation: the why, the what, the when, and the how
thumbnail
Congress Presentation
Optimisation of timing and approach to implement guideline-directed medical therapy (GMDT) during admission
thumbnail
Congress Presentation
Impact on adverse events of guideline-directed medical therapy for heart failure in patients with a systemic right ventricle

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources